Skip to main content

Table 5 Comparison between patients undergoing surgery at < 14 and > 14 days following PTGBD

From: The influence of the interval between percutaneous transhepatic gallbladder drainage and cholecystectomy on perioperative outcomes: a retrospective study

Factors

≤ 14-day group (n = 10)

≥ 15-day group (n = 12) P

P

Gender (Male), n (%)

9 (64.3)

5 (62.5)

0.9333

Age (years)

75.4 ± 2.7

77.5 ± 3.5

0.6324

Comorbidity (Yes), n (%)

10 (71.4)

8 (100.0)

0.0426

Anticoagulant medication (Yes), n (%)

2 (14.3)

0 (0.0)

0.1658

ASA status

2.36 ± 0.18

2.38 ± 0.24

0.9529

Cholecystitis grade

1.9 ± 0.2

1.5 ± 0.2

0.2092

WBC before PTBGD (/mL)

13,141 ± 1800

14,402 ± 2382

0.6771

CRP before PTGBD (mg/dL)

18.19 ± 2.85

14.80 ± 3.77

0.4807

WBC before surgery (/mL)

10,191 ± 1492

7198 ± 1973

0.2404

CRP before surgery (mg/dL)

11.13 ± 2.00

0.99 ± 2.64

0.0007

Surgical complications (Yes), n (%)

1 (7.1)

1 (12.5)

0.6795

Operating time (min)

117.4 ± 10.6

128.5 ± 14.1

0.5345

Blood loss (g)

176.1 ± 63.8

116.1 ± 84.4

0.5772

Adhesion grade

1.6 ± 0.2

1.9 ± 0.3

0.5082

Laparotomy conversion (Yes), n (%)

5 (35.7)

2 (25.0)

0.5999

Hospitalization after surgery (days)

12.8 ± 4.9

25.9 ± 6.5

0.1259

Total hospitalization (days)

19.5 ± 7.2

59.9 ± 9.5

0.0060

  1. Bold values indicate significant differences
  2. Data are presented as mean ± standard deviation unless otherwise indicated
  3. ≤ 14-day group: patients with an interval between PTGBD and surgery ≤ 14 days, ≥ 15-day group: patients with an interval between PTGBD and surgery ≥ 15 days, PTGBD: percutaneous transhepatic gallbladder drainage, WBC: white blood cell, CRP: C-reactive protein, ASA: American Society of Anesthesiologists